Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
| minor |
APROKAM 50 mg, powder for solution for injection, provides a minor improvement in actual benefit (IAB IV) compared with standard management of postoperative endophthalmitis associated with cataract surgery. |
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
AV5z2SAxMN3LYdA4
